Pascale Witz - Net Worth and Insider Trading

Pascale Witz Net Worth

The estimated net worth of Pascale Witz is at least $283,313 dollars as of 2024-05-24. Pascale Witz is the Director of Revvity Inc and owns about 2,446 shares of Revvity Inc (RVTY) stock worth over $275,762. Pascale Witz is also the Director of Regulus Therapeutics Inc and owns about 3,785 shares of Regulus Therapeutics Inc (RGLS) stock worth over $7,551. Details can be seen in Pascale Witz's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Pascale Witz has not made any transactions after 2019-11-21 and currently still holds the listed stock(s).

Transaction Summary of Pascale Witz

To

Pascale Witz Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Pascale Witz owns 4 companies in total, including Horizon Therapeutics PLC (HZNP) , Regulus Therapeutics Inc (RGLS) , and Revvity Inc (RVTY) among others .

Click here to see the complete history of Pascale Witz’s form 4 insider trades.

Insider Ownership Summary of Pascale Witz

Ticker Comapny Transaction Date Type of Owner
HZNP Horizon Therapeutics PLC 2017-08-02 director
RGLS Regulus Therapeutics Inc 2019-05-07 director
RVTY Revvity Inc 2019-11-21 director
2019-01-22 director

Pascale Witz Latest Holdings Summary

Pascale Witz currently owns a total of 2 stocks. Among these stocks, Pascale Witz owns 2,446 shares of Revvity Inc (RVTY) as of November 21, 2019, with a value of $275,762 and a weighting of 97.33%. Pascale Witz also owns 3,785 shares of Regulus Therapeutics Inc (RGLS) as of May 7, 2019, with a value of $7,551 and a weighting of 2.67%.

Latest Holdings of Pascale Witz

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
RVTY Revvity Inc 2019-11-21 2,446 112.74 275,762
RGLS Regulus Therapeutics Inc 2019-05-07 3,785 2.00 7,551

Holding Weightings of Pascale Witz


Pascale Witz Form 4 Trading Tracker

According to the SEC Form 4 filings, Pascale Witz has made a total of 1 transactions in Revvity Inc (RVTY) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Revvity Inc is the sale of 1,043 shares on November 21, 2019, which brought Pascale Witz around $94,569.

According to the SEC Form 4 filings, Pascale Witz has made a total of 0 transactions in Regulus Therapeutics Inc (RGLS) over the past 5 years. The most-recent trade in Regulus Therapeutics Inc is the acquisition of 2,963 shares on May 7, 2019, which cost Pascale Witz around $32,000.

Insider Trading History of Pascale Witz

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Pascale Witz Trading Performance

GuruFocus tracks the stock performance after each of Pascale Witz's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Pascale Witz is -49.23%. GuruFocus also compares Pascale Witz's trading performance to market benchmark return within the same time period. The performance of stocks bought by Pascale Witz within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Pascale Witz's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Pascale Witz

Average Return

Average return per transaction

Outperforming Transactions

0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -25.18
Relative Return to S&P 500(%) -24.81

Pascale Witz Ownership Network

Ownership Network List of Pascale Witz

No Data

Ownership Network Relation of Pascale Witz


Pascale Witz Owned Company Details

What does Horizon Therapeutics PLC do?

Who are the key executives at Horizon Therapeutics PLC?

Pascale Witz is the director of Horizon Therapeutics PLC. Other key executives at Horizon Therapeutics PLC include EVP and Chief Business Officer Andy Pasternak , EVP & Chief Financial Officer Aaron Cox , and EVP & Chief Medical Officer Jeffrey W Sherman .

Horizon Therapeutics PLC (HZNP) Insider Trades Summary

Over the past 18 months, Pascale Witz made no insider transaction in Horizon Therapeutics PLC (HZNP). Other recent insider transactions involving Horizon Therapeutics PLC (HZNP) include a net sale of 40,275 shares made by Jeffrey W Sherman , a net sale of 57,298 shares made by Andy Pasternak , and a net sale of 36,148 shares made by Aaron Cox .

In summary, during the past 3 months, insiders sold 0 shares of Horizon Therapeutics PLC (HZNP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 133,721 shares of Horizon Therapeutics PLC (HZNP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 133,721 shares.

Horizon Therapeutics PLC (HZNP)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Horizon Therapeutics PLC Insider Transactions

No Available Data

Pascale Witz Mailing Address

Above is the net worth, insider trading, and ownership report for Pascale Witz. You might contact Pascale Witz via mailing address: C/o Regulus Therapeutics Inc., 10614 Science Center Drive, San Diego Ca 92121.

Discussions on Pascale Witz

No discussions yet.